A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer
Clinical trial NCT01256567 · COMPLETED
Trial details
- NCT number
- NCT01256567
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2012-11-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.